Prof. Avan Aihie Sayer
Health, Academic Medicine
Health
Medical Oncology, focus on interdisciplinary, translational research, aiming for personalized medicine.
Breast cancer research: clinical trials, long-term consequences of a breast cancer diagnosis.
Diagnosis and therapy of neuroendocrine tumors.
Translational oncology: Exploiting the apoptotic route for cell death induction with focus on the TRAIL route and early clinical trials with novel anticancer agents.
Molecular imaging: Her molecular imaging research focuses on neuroendocrine tumors and the visualization of tumor specific targets including cancer drug targets, and in particular in breast cancer.
Member of the Royal Netherlands Academy of Arts and Sciences (KNAW) since 2002.
Knight in the Order of the Netherlands Lion 2008.
European Society of Medical Oncology (ESMO) award, 2009.
Fellow of European Academy of Cancer Sciences, 2009.
Member Governing Body European Academy of Cancer Sciences, 2010.
KNAW Academy Professorship, 2010.
Winners of the Marie Curie Award 2010. European Association of Nuclear Medicine. VEGF immuno-PET with 89Zr-ranibizumab during sunitinib treatment. MN Lub-de Hooge, WB Nagengast, JA Gietema, SF Oosting, MA de Korte, F Warnders, H Timmer-Bosscha, GA Hospers, JR de Jong, WF den Dunnen, H Hollema, RAJO Dierckx, EGE de Vries.
The Michel Clavel Lecturer at the 22nd EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics" in Berlin 2010. Title: "Novel molecular imaging for early drug development".
Golden Crab of the Dutch Cancer Society, 2011
European Research Council (ERC) Advanced Investigator Grant 2011
Dutch, English
Yao YC, Shah MH, Ito T, Bohas CL, Wolin EM, van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K. Everolimus for advanced pancreatic neuroendocrine tumors. New Engl J Med. 2011;364:514-23.
Nagengast WB, Lub-de Hooge MN, Oosting SF, den Dunnen WF, Warnders FJ, Brouwers AH, de Jong JR, Price PM, Hollema H, Hospers GA, Elsinga PH, Hesselink JW, Gietema JA, de Vries EG. VEGF-PET imaging is a non-invasive biomarker showing differential changes in the tumor during sunitinib treatment. Cancer Res. 2011;71:143-53.
de Vries EG, de Jong S. Exploiting the apoptotic route for cancer treatment: a single hit will rarely result in a home run. J Clin Oncol. 2008;26:5151-3.
Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol. 2008;26:1489-95.
Buijs C, Rodenhuis S, Seynaeve CM, van Hoesel QG, van der Wall E, Smit WJ, Nooij MA, Voest E, Hupperets P, TenVergert EM, van Tinteren H, Willemse PH, Mourits MJ, Aaronson NK, Post WJ, de Vries EG. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life. J Clin Oncol. 2007;25:5403-9.
Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, van der Horst-Schrivers AN, Jager PL. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol. 2006;7:728-34.
Perik PJ, Lub-De Hooge MN, Gietema JA, van der Graaf WT, de Korte MA, Jonkman S, Kosterink JG, van Veldhuisen DJ, Sleijfer DT, Jager PL, de Vries EG. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2006;24:2276-82.
Nieboer P, Buijs C, Rodenhuis S, Seynaeve C, Beex LV, van der Wall E, Richel DJ, Nooij MA, Voest EE, Hupperets P, Mulder NH, van der Graaf WT, TenVergert EM, van Tinteren H, de Vries EG. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol. 2005;23:8296-304.
Hoekstra R, de Vos FY, Eskens FA, Gietema JA, van der Gaast A, Groen HJ, Knight RA, Carr RA, Humerickhouse RA, Verweij J, de Vries EG. Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. J Clin Oncol. 2005;23:5188-97.
Rodenhuis S, Bontenbal M, Beex LV, Wagstaff J, Richel DJ, Nooij MA, Voest EE, Hupperets P, van Tinteren H, Peterse HL, TenVergert EM, de Vries EG; Netherlands Working Party on Autologous Transplantation in Solid Tumors. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med. 2003;349:7-16.
The American Womens Club of the Hague Grant; Pink Gala, Molecular imaging in breast cancer.
Pink Ribbon Grant 2008: VEGF imaging for early breast cancer detection.
Pink Ribbon Grant 2008: Improvement of psycho-social care for breast cancer patients.
Dutch Cancer Society grant RUG 2009: Molecular imaging as biomarker of HSP90 inhibition pharmacodynamics in breast cancer.
CTMM (Center for Translational and Molecular Medicine) grant 2009: Mammary Carcinoma Molecular Imaging for Diagnosis and Therapeutics (MAMMOTH), PI: EGE de Vries, UMCG, in collaboration with UMCU, VUMc, TUe, Philips, Roche, BG Medicine & small biotech companies.
Dutch Cancer Society 2010 fellowship: In vivo analysis of IGF-1R, ER and VEGF expression in trastuzumab resistant breast cancer before and after drug intervention. for AGT Terwisscha van Scheltinga.
Dutch Cancer Society RUG 2009-4529: FES-PET as a predictive biomarker for response to estrogen therapy in metastatic breast cancer patients.
Royal Academy of Science (KNAW) professorship.
ESMO Translational Research Fellowship 2010, K Tamas, Budapest, Hungary. Medical oncologist: Tumor microenvironment with focus on the role of PIGF and colon cancer.
European Research Council (ERC) Advanced Investigator Grant 2011: OnQview: Non-Radioactive Molecular Imaging-Driven Drug Development in Oncology.
Dutch Society of Clinical Pharmacology
Dutch Society of Oncology
Dutch Society of Internists
Dutch Society of Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
European Society of Medical Oncology
Patient Care: Certified for Internal Medicine, Medical Oncology and Clinical Pharmacology.
Participates in all aspects of clinical care in the Department of Medical Oncology: outpatients, clinic, and consultations.
Participates in training of internists and medical oncologists.
Coordinates clinical studies.
2 daughters, Josée (1984) and Esther (1986)
You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here
Health, Academic Medicine
Health, Brain research
Biological and related sciences, Health, Neuroscience
Health, Obesity, Diabetes, Immunology